Viewing nowSidipo Tablet 25 mg (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 28.34mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

MFDS item code 202102609 · Approved 2021.03.25 · Insurance code 645907160
Improvement of glycemic control in type 2 diabetes mellitus
This drug is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can control blood sugar as a monotherapy, but if the patient has never used diabetes medications and if monotherapy is insufficient, it may be combined with Metformin. Furthermore, this drug can be added when blood sugar control is difficult with monotherapy of sulfonylureas, Metformin, thiazolidinediones, or insulin. If adequate blood sugar control is not achieved even with various combination therapies, this drug is used additionally to improve blood sugar control. Therefore, this drug is effectively used to improve blood sugar control in various cases.
This medicine is administered at 100 mg once daily, either as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Because dosage adjustment according to renal function is necessary, assessment of renal function is recommended before and periodically during treatment with this medicine. 1. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.
This drug can rarely cause serious allergic reactions; hence, if symptoms such as rash, difficulty breathing, or swelling of the face or neck occur within three months of administration, it should be stopped immediately and a doctor should be consulted. Acute pancreatitis, which is inflammation of the pancreas, has been reported; if abdominal pain, vomiting, or persistent abdominal discomfort develops, this drug should be discontinued and medical attention sought immediately. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis, and it should not be used if there is an allergy to this drug or any of its components. In patients with impaired renal function, the excretion of this drug may be delayed, requiring dosage adjustment; regular renal function tests before and during administration are important. In clinical trials, symptoms such as upper respiratory tract infections, headaches, and nasopharyngitis were reported during the use of this drug, and caution is needed, especially when taken with other antihyperglycemic agents as hypoglycemic symptoms may occur. When used in combination with insulin or sulfonylureas, the risk of hypoglycemia increases, so patients must be aware of hypoglycemic symptoms and adjust the dosage of these drugs as necessary. Rare side effects such as severe arthralgia or bullous pemphigoid have also been reported; if such symptoms occur, the doctor should be informed immediately. Pregnant or breastfeeding women should refrain from taking this drug, and its safety and efficacy have not been established in children and adolescents under 18 years of age. Elderly patients may have impaired renal function, necessitating dosage adjustment and renal function monitoring. In case of overdose, general treatment should be provided, and if necessary, blood dialysis can be performed to remove the drug, so immediate medical assistance should be sought in emergencies. Also, this drug may interact with certain medications, so it is crucial to inform healthcare providers of any other medications being taken.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to prevent air intrusion, and the storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature. Storing the drug this way helps maintain its effectiveness for an extended period.
Bright yellow-orange round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 28.34mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.